Several short-term and long-term clinical trials have shown that the addition of pramlintide to preexisting insulin therapy improved postprandial and overall glycemic control (hemoglobin A 1c ...

In contrast, glargine insulin had no effect on blood pressure, HDL cholesterol, or triglyceride levels but significantly reduced total and LDL cholesterol ( Table 1). At present, it is not ...